Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials

Open Access

Peer-reviewed

Research Article

Jakob Doblinger,

Affiliation Department of Obstetrics and Gynecology, Paracelsus Medical University, Salzburg, Austria
⨯
Barbara Cometti,

Affiliation IBSA Institut Biochimique SA, R&D Scientific Affairs, Lugano, Switzerland
⨯
Silvia Trevisan,

Affiliation IBSA Institut Biochimique SA, R&D Scientific Affairs, Lugano, Switzerland
⨯
Georg Griesinger

* E-mail: georg.griesinger@uni-luebeck.de

Affiliation Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
⨯

Reader Comments (0)

Progesterone
Is the Subject Area "Progesterone" applicable to this article?

Thanks for your feedback.
Pregnancy
Is the Subject Area "Pregnancy" applicable to this article?

Thanks for your feedback.
Oocytes
Is the Subject Area "Oocytes" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Ovaries
Is the Subject Area "Ovaries" applicable to this article?

Thanks for your feedback.
Embryo transfer
Is the Subject Area "Embryo transfer" applicable to this article?

Thanks for your feedback.